Cidara Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CDTX for the last quarter is 17.58 M USD, and it's 38.25% higher compared to the previous quarter. The net income of Q4 23 is -5.61 M USD.